187. ESMO Awards - Episode 7

187. ESMO Awards - Episode 7

Up next

188. Gastrointestinal Cancer and Professor Jenny Seligmann

Today, our guest is a transformative figure in bowel cancer treatment. Professor Jenny Seligmann, a Consultant Medical Oncologist and Professor of Gastrointestinal and Translational Oncology at the University of Leeds, is renowned for leading the groundbreaking FOxTROT and ARIEL ...  Show more

186. ESMO Awards - Episode 6

ESMO Episode 6 is here! The longest award ceremony in the world continues. This episode covers colorectal cancer, a cancer stream that has relied heavily on the same three drugs for the past twenty-five years.We cover the golden pinnacle of real-world use cases for CTDNA, neoadju ...  Show more

Recommended Episodes

Episode 104: Colorectal Cancer Series, Pt. 6 - Colorectal Cancer Pharmacology
The Fellow on Call: The Heme/Onc Podcast

We have another guest joining us this week! Dr. Allison Schepers, PharmD, BCOP is a Clinical Pharmacist Specialist at the Rogel Cancer Center at the University of Michigan where she focuses on GI, GU, and Thoracic malignancies! In this episode, Allison discusses the high yield ...

  Show more

Episode 108: Colorectal Cancer Series, Pt. 10 - Metastatic Colorectal Cancer (Part 2)
The Fellow on Call: The Heme/Onc Podcast

This week, we round out our discussion on metastatic colorectal cancer, focusing on more targeted therapies for this disease. If you have not done so already, be sure to check out episode 107 for the first part of our metastatic colorectal cancer discussion.

Contents: </ ...

  Show more

Chemotherapy: IPC and HIPEC
Ready, Set, GYO!

In this episode, we discuss Intraperitoneal chemotherapy (IPC) and Heated Intraperitoneal Chemotherapy (HIPEC), including clinical trials of these agents in ovarian cancer, complications and practical tips for utilizing HIPEC in clinical practice. Join us for bi-weekly episodes o ...  Show more

Survivorship
Ready, Set, GYO!

This is the last episode of our core curriculum series. In this episode we discuss cancer survivorship as it relates to gynecologic oncology. Additionally we provide a framework for surveillance visits as well the general timing based on primary malignancy. We also give a brief o ...  Show more